Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,873–1,880 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Greenwich LifeSciences Inc. GLSI-100 (GP2 + GM-CSF) HER2/neu breast cancer Phase 2b Intracutaneous Oncology
Greenwich LifeSciences Inc. GP2 (GLSI-100) - (FLAMINGO-01) HER2 positive breast cancer Phase 3 Data Released Intradermal Oncology
GRI Bio Inc. GRI-0621-IPF-02 Idiopathic pulmonary fibrosis (IPF) Phase 2a Data Released Oral Respiratory
GRI Bio Inc. GRI-0621-IPF-02 Idiopathic pulmonary fibrosis (IPF) Phase 2a Data Released Oral Respiratory
Grifols S.A. Prolastin-C (Alpha-1 MP) - (SPARTA) Alpha1 Antitrypsin Deficiency (AATD) Phase 3 Intravenous Genetic Disorder
Gritstone bio Inc. GRANITE-CRC-1L 1L Microsatellite-Stable Colorectal Cancer (MSS-CRC) Phase 2/3 Data Released Intravenous Oncology
Gritstone bio Inc. GRANITE-ADJUVANT High-risk stage II/III colon cancer Phase 2 Ongoing Intravenous Oncology
Gritstone bio Inc. SLATE Non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) Phase 2 Ongoing Oral Oncology